Abstract:Diabetes is a metabolic disease often characterized by elevated blood sugar levels, which is mainly treated through external injection of insulin. However, long-term insulin injection in patients will produce many adverse side effects such as hypoglycemia, subcutaneous fat atrophy and prolonged absorption, resulting in poor patient compliance. In this work, mesoporous silica (SBA-15) nanorods with large surface area (541.8 m 2 /g) were prepared via soft-templating method, which retained a large number of ordered mesoporous structures as the drug delivery carrier for insulin. Insulin-loaded mesoporous silica (SBA-15/INS) particle was obtained by solvent adsorption, which was then coated with hydroxypropyl methylcellulose phthalate (HP55) to form pH-sensitive mesoporous silica nanoparticles (HP55@SBA-15/INS). The surface area, structure and morphology of silica particles were addressed by BET, FTIR, XRD, SEM and TEM, indicating that SBA-15/INS and HP55@SBA-15/INS maintained the rod-like and ordered white strips structure similar to SBA-15. Also, insulin was found to be present in the mesoporous silica nanoparticles, with loading capacity and encapsulation efficiency reaching 25.5 % and 80.9 %, respectively. The vitro release results revealed that insulin release in the simulated gastric fluid (SGF, pH = 1.2) was significantly slower than that in the simulated intestinal fluid (SIF, pH = 7.4). Compared with SBA-15/INS, the release percentages in 15 % HP55@SBA-15/INS decreased 30 % in SGF, while it increased approximately 10 % in SIF. Kinetics analysis showed that the release process in HP55@SBA-15/INS was a Fick diffusion in both SGF and SIF and HP55 was degraded in SIF, resulting in accelerated insulin release. The cytotoxicity evaluation results showed that the cell viability of 4T1 after 24 h incubated with SBA-15 and 15 % HP55@SBA-15/INS was both approximately 100 %, demonstrating that the facile manufactured method has great potential to prepare macromolecular drug nanoparticle for oral release. Graphical abstract Fig.1 Schematic illustration of the fabrication of HP55@SBA-15/INS and its application in oral delivery of insulinThis paper reports a facile synthesis of pH-responsive mesoporous silica nanorod for oral delivery of insulin. As shown in Fig.1, insulin-loaded mesoporous silica (SBA-15/INS) particle was obtained by solvent adsorption, which was then coated with hydroxypropyl methylcellulose phthalate (HP55) to form pH-sensitive mesoporous silica nanoparticles (HP55@SBA-15/INS) via double emulsion solvent evaporation method. The insulin was found to be present in the mesoporous silica nanoparticles, with loading capacity and encapsulation efficiency reaching 25.5 % and 80.9 %, respectively. The HP55@SBA-15/INS nanoparticles show excellent release performance in simulated intestinal fluid (SIF, pH = 7.4) without observable cytotoxicity. And, the release process in HP55@SBA-15/INS is demonstrated to a Fick diffusion in SIF. More importantly, this synthesis method can be widely used to load other protein drug for oral delivery, which will produce various novel nanomedicines of different clinical applications. Download : Download high-res image (139KB) Download : Download full-size image

Bioinspired Zwitterionic Polyphosphoester Modified Porous Silicon Nanoparticles For Efficient Oral Insulin Delivery

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

Dual Stimuli-Responsive Nanoparticle-Incorporated Hydrogels As an Oral Insulin Carrier for Intestine-Targeted Delivery and Enhanced Paracellular Permeation.

Overcoming the Diffusion Barrier of Mucus and Absorption Barrier of Epithelium by Self-Assembled Nanoparticles for Oral Delivery of Insulin.

Thiolated Nanoparticles Overcome the Mucus Barrier and Epithelial Barrier for Oral Delivery of Insulin.

Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin

Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium

Chitosan-modified Porous Silicon Microparticles for Enhanced Permeability of Insulin Across Intestinal Cell Monolayers.

Beneficial Properties for Insulin Absorption Using Superporous Hydrogel Containing Interpenetrating Polymer Network As Oral Delivery Vehicles

pH-responsive mesoporous silica nanorod for high load and oral delivery of insulin

Enhancing Insulin Oral Absorption by Using Mucoadhesive Nanoparticles Loaded with LMWP-linked Insulin Conjugates.

Overcoming Oral Insulin Delivery Barriers: Application of Cell Penetrating Peptide and Silica-Based Nanoporous Composites

Efficient Mucus Permeation and Tight Junction Opening by Dissociable "Mucus-Inert" Agent Coated Trimethyl Chitosan Nanoparticles for Oral Insulin Delivery.

Enhanced Oral Delivery of Insulin Via Loading in Polysorbate-80 Micelles

Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec)

Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.

pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery

Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery

HP55-coated Capsule Containing PLGA/RS Nanoparticles for Oral Delivery of Insulin.

Goblet Cell Targeting Nanoparticle Containing Drug-Loaded Micelle Cores for Oral Delivery of Insulin.

Polymer Integrity Related Absorption Mechanism of Superporous Hydrogel Containing Interpenetrating Polymer Networks for Oral Delivery of Insulin.